Company intelligence / Profile preview

PolyMedics

Kirchheim unter Teck, Germany

Ownership: Private
Development stage: Other

Overview

PolyMedics Innovations develops and commercializes synthetic biomaterials for wound treatment, including SUPRATHEL®, SUPRA SDRM®, SUPRA NET®, and distribution of NexoBrid® and ReCell® in select markets. Products are clinically proven, available in over 40 countries, and used on over 250,000 patients.

Therapeutic areas: Dermatology
Industry: Consumable Medical Devices

Partnerships

MediWound (NexoBrid® distribution in Germany, Austria, Belgium, Netherlands, Luxembourg)Avita Medical (ReCell® distribution)PolyNovo Biomaterials (NovoSorb® distribution in DACH, Benelux, Sweden)

Beyond the preview

Go deeper on PolyMedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PolyMedics.

Explore the full profile